OVERCOMING

LIMITS

ANNUAL REPORT 2017

EN     PT

  • INVESTMENTS

    Alenia capsules, medicine for treatment of respiratory diseases

INVESTMENTS

BRL 90,4 million

invested in innovation, which represent 10.4% of EBITDA.

BRL 41,1 million

 in operational excellence, including actions of ecoefficiency.

BRL 31,6 million

million in training and career development programs.

BRL 11,7 million

million in projects which promote culture,
 education, sports, social inclusion,
 health and environmental preservation.

BRL 4,9 million

in Quality.

Aché

Right Menu IconMENU